Neuralink Gets FDA Green Light for Second Patient, as First Describes His Emotional Journey

Petosemtamab Receives FDA Breakthrough Therapy Designation: Head / Neck Cancers

Did Neuralink Ignore Early Trial Risk? Brain Implant Issues Plagued Lab Before Human Case

Neuralink’s First Patient: ‘It Blows My Mind So Much’